Simple Summary Mesenchymal chondrosarcoma (MCS) is a subtype of chondrosarcoma
with rare occurrence and poor survival rates. MCS stains positive for S-100 and SOX9 as …

Cancer research remains clinically unmet in many areas due to limited access to patient
samples and the lack of reliable model systems that truly reflect human cancer biology. The …

We describe a case of a pleomorphic adenoma (PA) arising from the para‐tracheal
accessory salivary gland in a 44‐year‐old male harboring a novel WWTR1:: NCOA2 gene …

Objectives We conducted a retrospective multi‐centre study to assess the real‐world
outcome of regorafenib (REGO) and cabozantinib (CABO) in recurrent/refractory bone …

Chondrosarcoma (CS), the second most common malignant bone tumor after osteosarcoma,
accounts for 20–30% of all malignant bone tumors. It mainly affects adults, middle-aged, and …

We describe a case of a myoepithelial carcinoma of the superficial parotid gland in a 46‐
year‐old male harboring a novel CTCF:: NCOA2 gene fusion. To our knowledge, this novel …

Mesenchymal chondrosarcoma is a rare and aggressive sarcoma subtype with high risk for
distant metastases and poor prognosis. Currently NCCN-and ESMO-Guidelines recommend …

Aims Although molecular tests developed for a growing list of oncogenic alterations have
significantly aided in the classification of head and neck carcinomas, tumours in which …

Cartilage-forming tumors are a broad and diverse group of neoplasms frequently affecting
the skeleton. Distinguishing between the members of this group is important because of …

Introduction Mesenchymal chondrosarcoma (MCS) is a rare subtype of chondrosarcoma that
occurs at widespread anatomical locations, such as bone, soft tissue, and intracranial sites …